Cargando…

Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online?

BACKGROUND: The use of computerized systems to support evidence-based practice is commonplace in contemporary medicine. Despite the prolific use of electronic support systems there has been relatively little research on the uptake of web-based systems in the oncology setting. Our objective was to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Langton, Julia M, Pesa, Nicole, Rushton, Shelley, Ward, Robyn L, Pearson, Sallie-Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606250/
https://www.ncbi.nlm.nih.gov/pubmed/23497080
http://dx.doi.org/10.1186/1471-2407-13-112
_version_ 1782263974915473408
author Langton, Julia M
Pesa, Nicole
Rushton, Shelley
Ward, Robyn L
Pearson, Sallie-Anne
author_facet Langton, Julia M
Pesa, Nicole
Rushton, Shelley
Ward, Robyn L
Pearson, Sallie-Anne
author_sort Langton, Julia M
collection PubMed
description BACKGROUND: The use of computerized systems to support evidence-based practice is commonplace in contemporary medicine. Despite the prolific use of electronic support systems there has been relatively little research on the uptake of web-based systems in the oncology setting. Our objective was to examine the uptake of a web-based oncology protocol system (http://www.eviq.org.au) by Australian cancer clinicians. METHODS: We used web-logfiles and Google Analytics to examine the characteristics of eviQ registrants from October 2009-December 2011 and patterns of use by cancer clinicians during a typical month. RESULTS: As of December 2011, there were 16,037 registrants; 85% of whom were Australian health care professionals. During a typical month 87% of webhits occurred in standard clinical hours (08:00 to 18:00 weekdays). Raw webhits were proportional to the size of clinician groups: nurses (47% of Australian registrants), followed by doctors (20%), and pharmacists (14%). However, pharmacists had up to three times the webhit rate of other clinical groups. Clinicians spent five times longer viewing chemotherapy protocol pages than other content and the protocols viewed reflect the most common cancers: lung, breast and colorectal. CONCLUSIONS: Our results demonstrate eviQ is used by a range of health professionals involved in cancer treatment at the point-of-care. Continued monitoring of electronic decision support systems is vital to understanding how they are used in clinical practice and their impact on processes of care and patient outcomes.
format Online
Article
Text
id pubmed-3606250
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36062502013-03-23 Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online? Langton, Julia M Pesa, Nicole Rushton, Shelley Ward, Robyn L Pearson, Sallie-Anne BMC Cancer Research Article BACKGROUND: The use of computerized systems to support evidence-based practice is commonplace in contemporary medicine. Despite the prolific use of electronic support systems there has been relatively little research on the uptake of web-based systems in the oncology setting. Our objective was to examine the uptake of a web-based oncology protocol system (http://www.eviq.org.au) by Australian cancer clinicians. METHODS: We used web-logfiles and Google Analytics to examine the characteristics of eviQ registrants from October 2009-December 2011 and patterns of use by cancer clinicians during a typical month. RESULTS: As of December 2011, there were 16,037 registrants; 85% of whom were Australian health care professionals. During a typical month 87% of webhits occurred in standard clinical hours (08:00 to 18:00 weekdays). Raw webhits were proportional to the size of clinician groups: nurses (47% of Australian registrants), followed by doctors (20%), and pharmacists (14%). However, pharmacists had up to three times the webhit rate of other clinical groups. Clinicians spent five times longer viewing chemotherapy protocol pages than other content and the protocols viewed reflect the most common cancers: lung, breast and colorectal. CONCLUSIONS: Our results demonstrate eviQ is used by a range of health professionals involved in cancer treatment at the point-of-care. Continued monitoring of electronic decision support systems is vital to understanding how they are used in clinical practice and their impact on processes of care and patient outcomes. BioMed Central 2013-03-12 /pmc/articles/PMC3606250/ /pubmed/23497080 http://dx.doi.org/10.1186/1471-2407-13-112 Text en Copyright ©2013 Langton et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Langton, Julia M
Pesa, Nicole
Rushton, Shelley
Ward, Robyn L
Pearson, Sallie-Anne
Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online?
title Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online?
title_full Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online?
title_fullStr Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online?
title_full_unstemmed Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online?
title_short Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online?
title_sort uptake of a web-based oncology protocol system: how do cancer clinicians use eviq cancer treatments online?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606250/
https://www.ncbi.nlm.nih.gov/pubmed/23497080
http://dx.doi.org/10.1186/1471-2407-13-112
work_keys_str_mv AT langtonjuliam uptakeofawebbasedoncologyprotocolsystemhowdocancercliniciansuseeviqcancertreatmentsonline
AT pesanicole uptakeofawebbasedoncologyprotocolsystemhowdocancercliniciansuseeviqcancertreatmentsonline
AT rushtonshelley uptakeofawebbasedoncologyprotocolsystemhowdocancercliniciansuseeviqcancertreatmentsonline
AT wardrobynl uptakeofawebbasedoncologyprotocolsystemhowdocancercliniciansuseeviqcancertreatmentsonline
AT pearsonsallieanne uptakeofawebbasedoncologyprotocolsystemhowdocancercliniciansuseeviqcancertreatmentsonline